PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
38.07%
Net income growth under 50% of CRK's 80.39%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-5.43%
Both reduce yoy D&A, with CRK at -86.19%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
17.62%
Lower deferred tax growth vs. CRK's 148.69%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
275.00%
SBC growth while CRK is negative at -36.30%. John Neff would see competitor possibly controlling share issuance more tightly.
1.72%
Slight usage while CRK is negative at -273.32%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-53.82%
Both yoy AR lines negative, with CRK at -13.76%. Martin Whitman would suspect an overall sector lean approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.72%
Some yoy usage while CRK is negative at -97.76%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-253.19%
Both negative yoy, with CRK at -118.08%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-64.96%
Both yoy CFO lines are negative, with CRK at -569.58%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-28.21%
Negative yoy CapEx while CRK is 54.70%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-99.34%
Negative yoy acquisition while CRK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
290.96%
Purchases growth of 290.96% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-95.71%
We reduce yoy sales while CRK is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-27.76%
We reduce yoy other investing while CRK is 559.26%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-217.12%
We reduce yoy invests while CRK stands at 57.73%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
78.13%
Debt repayment at 75-90% of CRK's 100.00%. Bill Ackman urges more debt clearance to match competitor’s lower leverage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.